ArticlePloS one2025
Psychophysiology of facial emotion recognition in psychopathy dimensions and oxytocin's role: A scoping review.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Translational pathways of oxytocin therapy in schizophrenia: bridging negative symptom domains and neural mechanisms.Translational psychiatry · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Psychopathy is characterized by social impairments that hinder effective societal functioning. It comprises two main dimensions: "Interpersonal-affective" and "Lifestyle-antisocial," each associated with distinct patterns of traits and central and peripheral neurocorrelates, particularly concerning social salience and oxytocin function. In this review, we systematically identified and synthesized evidence from studies investigating oxytocin's role in the psychophysiological correlates of emotion recognition across psychopathy dimensions. However, as no such direct studies were identified, we instead compiled and analyzed research examining these variables separately. A scoping review was conducted to capture studies reporting on psychopathy or oxytocin in relation to facial emotion recognition, whether or not they included central or peripheral psychophysiological measurements - retrieving 66 articles. We found distinct emotion recognition outcomes between psychopathy dimensions, some even with opposing neural activity in response to emotional expressions, particularly those of negative valence, as assessed through neuroimaging, electrophysiology, eye-gazing, and pupillometry. Oxytocin presented suggestive positive/compensatory effects on social salience, enhancing emotion recognition, and increasing pupil dilation, and eye-gazing towards faces, and decreasing brain activation towards negative emotions. This review highlights the critical need for future studies to bridge the gap between psychopathy and oxytocin research by exploring their interaction on shared psychophysiological correlates. Such efforts could facilitate the identification of dimension-specific diagnostic biomarkers and targeted interventions for psychopathy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.